Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in 
mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene 
disruption.

Uhr, M.; Steckler, T.; Yassouridis, A.; Holsboer, F.

Lokale TagsFreigabegeschichteDetailsÜbersicht

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene disruption.

Uhr, M., Steckler, T., Yassouridis, A., & Holsboer, F. (2000). Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene disruption. Neuropsychopharmacology, 22, 380-387.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-A544-2 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-A545-F

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Uhr, M.¹, Autor
Steckler, T., Autor
Yassouridis, A.², Autor
Holsboer, F.³, Autor

Affiliations:
1AG Uhr, Manfred, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607163
2Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137
3Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607139